France set to privatise Rhone Poulenc
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.RHONE POULENC, the chemicals and pharmaceuticals group, is to be the next sale in the French government's privatisation programme. It is expected to be followed by Elf Aquitaine, the oil company, writes Peter Rodgers.
The Rhone Poulenc announcement by Edmond Alphandery, the economics minister, came as shares in Banque Nationale de Paris reached a 19 per cent premium to the Fr240 ( pounds 28.60) offer price during the first day of trading since their privatisation.
After an initial suspension because they had broken their upward limits, the BNP shares hit a high during the day of Fr285.90.
This confirms widespread expectations, based on the non-voting shares that were already traded, that the shares would show an instant paper profit for investors.
Brokers said there was strong demand from institutions that had had their allocations scaled back because of high demand from private investors. Institutions were warned in advance that if the private offer was popular they would have their allocations cut. They were five times oversubscribed.
Shares in Elf and Rhone Poulenc, which are already traded on the Bourse, rose as a result of the announcement of the new privatisations.
But they are expected to be routine sales compared with the next large-scale privatisation of the insurance company Union des Assurances de Paris, which is likely to take place next spring.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments